4//SEC Filing
Nolan Lisa 4
Accession 0001140361-18-003894
CIK 0001228627other
Filed
Jan 29, 7:00 PM ET
Accepted
Jan 30, 4:31 PM ET
Size
5.2 KB
Accession
0001140361-18-003894
Insider Transaction Report
Form 4
Nolan Lisa
Chief Business Officer
Transactions
- Award
Stock Option (right to buy)
2018-01-26+42,101→ 42,101 totalExercise: $2.29Exp: 2028-01-26→ Common Stock (42,101 underlying)
Footnotes (1)
- [F1]One quarter of the option vests and becomes exercisable on January 26, 2019, and, thereafter, 1/36th of the remaining option vests in equal installments on the first business day of each month until fully vested.
Documents
Issuer
REXAHN PHARMACEUTICALS, INC.
CIK 0001228627
Entity typeother
Related Parties
1- filerCIK 0001661400
Filing Metadata
- Form type
- 4
- Filed
- Jan 29, 7:00 PM ET
- Accepted
- Jan 30, 4:31 PM ET
- Size
- 5.2 KB